Avenoso D, Radici V, Leoni A, Skert C, et al. A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first compl Bone Marrow Transplant 2026 Jun 24. doi: 10.1038/s41409-026-02937.
PMID: 42342968